Skip to main content
Equibles

RYLPF · Koninklijke Philips NV · Financials

Track RYLPF — free

Use RYLPF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RYLPF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.49 +0.76 (+3.18%) At close · Oct 6
Rebalance outlook locked
Market Cap
$24.40B
Shares
977.43M
Volume · Oct 6 390.53K Avg daily vol (18 sessions) 40.85K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
17.83B -1%
FY2025 Revenue FY2015–FY2025
Net Income
895M +227.5%
FY2025 Net Income FY2015–FY2025
Gross Margin
45.18% +2pp
FY2025 Gross Margin FY2015–FY2025
Operating Margin
7.98% +5pp
FY2025 Operating Margin FY2015–FY2025
Diluted EPS
0.93 +224%
FY2025 Diluted EPS FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
EUR 17.83B 18.02B 18.17B 17.83B 17.16B 17.31B 17.15B 18.12B 17.78B 17.42B 16.81B
EUR 9.78B 10.25B 10.72B 10.63B 9.99B 9.49B 9.25B 9.57B 9.6B 9.48B 9.59B
EUR 8.06B 7.77B 7.45B 7.19B 7.17B 7.82B 7.9B 8.55B 8.18B 7.94B 7.21B
EUR 1.7B 1.75B 1.89B 2.09B 1.81B 1.82B 1.79B 1.76B 1.76B 1.67B 1.56B
EUR 628M 582M 608M 671M 599M 630M 586M 631M 577M 658M 1B
EUR 1.13B 1.39B 1.26B 1.6B 1.32B 1.46B 1.34B 1.09B 1.03B 976M 972M
EUR 1.42B 529M -115M -1.53B 553M 1.26B 1.37B 1.72B 1.52B 1.46B 658M
EUR 346M 387M 376M 258M 188M 202M 233M 264M 263M 507M 453M
EUR 1.18B 123M -526M -1.73B 509M 1.21B 1.25B 1.5B 1.38B 1.03B 329M
EUR 282M 963M -73M -113M -103M 212M 258M 193M 349M 203M 169M
EUR 895M -702M -466M -1.61B 3.32B 1.19B 1.17B 1.09B 1.66B 1.45B 624M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: 7.41B in buybacks, 1.36B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2025-12-31 EUR 8,084,000,000 20-F filed 2026-02-19
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current borrowings, including current portion of noncurrent borrowings
EUR 1,151,000,000
Current portion of long-term borrowings
EUR 1,098,000,000
Noncurrent long-term borrowings
EUR 6,934,000,000
Short-term borrowings
EUR 52,000,000
Lease liabilities 2025-12-31 EUR 963,000,000 20-F filed 2026-02-19
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 313216 CUSIP 500472303 Visit website Investor relations